Bcrx ah trades

Author: cgoy

August undefined, 2024

WebMay 21, 2024 · NASDAQ: BCRX BioCryst Pharmaceuticals This commercial-stage drugmaker trades for less than many of its clinical-stage peers. Shares of BioCryst ( … WebFeb 22, 2024 · BCRX has 173 million shares outstanding and has a current price of $11.50 a share. This means BioCryst has a current market value of $1.9 billion. It is extremely …

William P Sheridan - BCRX / BioCryst Pharmaceuticals, Inc. - Fintel

WebData is delayed at least 15 minutes. Nasdaq.com will report pre-market and after hours trades. Pre-Market trade data will be posted from 4:15 a.m. ET to 7:30 a.m. ET of the … WebStock Price Target BCRX Advertisement Options Overview Research & Ratings Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume... mit wrap

Biocryst Pharmaceuticals (BCRX) Option Chain Market Chameleon

WebBioCryst Pharmaceuticals, Inc. is a commercial-stage biotechnology company that discovers novel, oral, and small-molecule medicines. The firm focuses on the treatment of rare … WebApr 12, 2024 · BCRX Insider Trading Activity BioCryst Pharmaceuticals Insider Buys and Sells NASDAQ:BCRX BioCryst Pharmaceuticals - BCRX Insider Trading & Ownership … WebBCRX Stock Price and Chart — NASDAQ:BCRX — TradingView 8.68 USD +0.15 +1.76% Markets / US Stocks / Health Technology / Biotechnology / BCRX BioCryst … mit wrestling team

BioCryst Pharmaceuticals, Inc. (BCRX) - Yahoo Finance

BCRX Stock Price BioCryst Pharmaceuticals Inc. Stock Quote …

WebBCRX Price $8.56 Fair Value Price $10.19 Market Cap $1.61B 52 Week Low $7.61 52 Week High $18.00 P/E -6.44x P/B -5.48x P/S 7.88x PEG N/A Dividend Yield N/A Revenue $270.83M Earnings -$247.12M Gross Margin 97.6% Operating Margin -53.65% Profit Margin -91.2% Debt to Equity -2.87 Operating Cash Flow -$162M Beta 1.3 Next Earnings May 3, … WebJan 8, 2007 · BioCryst is a late-stage biotech company that is committed to delivering extraordinary medicines that help patients live ordinary lives. At BioCryst, we are … mit wrestling clubWebBioCryst Pharmaceuticals, Inc. (BCRX) Stock Price, News, Quote & History - Yahoo Finance Dow 30 Nasdaq +91.09(+0.76%) Russell 2000 +2.33(+0.13%) Crude Oil -0.24( … ingo wilts hugo boss

"WebBCRX : 8.68 (+1.76%) Wall Street Analysts Predict a 48% Upside in BioCryst (BCRX): Here's What You Should Know Zacks - Wed Jan 4, 8:55AM CST. The mean of analysts' price targets for BioCryst (BCRX) points to a 47.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among … " - Bcrx ah trades

Bcrx ah trades

WebView Latest Real Time Trades Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly... WebWilliam P Sheridan - BCRX / BioCryst Pharmaceuticals, Inc. - Insider Trade Report EXTENDED This page shows the track record and history of Sheridan William P insider trades in BioCryst Pharmaceuticals, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company.

Did you know?

WebApr 5, 2024 · BioCryst Pharma. (BCRX) is scheduled to report earnings on May 4, 2024.The last reported earnings were for reported on February 21, 2024 for Q4. WebBioCryst (BCRX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season. BCRX : 8.68 (+1.76%) Earnings …

WebLast 100 Trades Back to BCRX Overview About Latest Pre-Market Trades Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day.... WebBCRX Stock 12 Months Forecast. Average Price Target. $14.71 (76.38% Upside) Based on 7 Wall Street analysts offering 12 month price targets for BioCryst in the last 3 months. The average price target is $14.71 with a high forecast of $30.00 and a low forecast of $8.00.

WebNext quarter’s sales forecast for BCRX is $71.12M with a range of $68.50M to $78.63M. The previous quarter’s sales results were $79.55M. BCRX beat its sales estimates 75.00% of … WebBioCryst Pharmaceuticals, Inc. (BCRX) Stock Historical Prices & Data - Yahoo Finance U.S. markets close in 4 hours 22 minutes Dow 30 +83.53(+0.25%) Nasdaq 12,014.30 -70.05(-0.58%) Russell 2000...

WebMar 31, 2024 · The stock currently trades at $79.67 and it is a top-three stake at ~12% of the portfolio. There was a ~5% stake increase this quarter at ~$72 per share. Note: …

WebApr 3, 2024 · A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BCRX shares currently have a short interest ratio of 10.0. Learn More on BioCryst Pharmaceuticals's short interest ratio. mitx bootcampWebView the latest BioCryst Pharmaceuticals Inc. (BCRX) stock price, news, historical charts, analyst ratings and financial information from WSJ. BCRX BioCryst Pharmaceuticals … ingo winter frankfurtWebMar 31, 2024 · As a feature of Market Chameleon's option chain, you can view the list of option trades for each individual Biocryst Pharmaceuticals (BCRX) option by clicking on the corresponding volume number in the table above. It will bring up a … mit wsj account